HIV

CD4-HIV interactions may mediate type I interferon production.

Raltegravir in long-acting formulation may only be needed every month in HIV patients.

Injections of new formulation of raltegravir may only be needed every month.

A pharmacist who pleaded guilty to criminal diversion of prescription medications and receipt of commercial bribes will pay $5.4 million to the New York State Medicaid Program and could serve 7 years in state prison.

Lamivudine is designed to treat HIV-1 infection in combination with other antiretroviral agents.

Lamivudine is a nucleoside analogue reverse transcriptase inhibitor designed to treat HIV-1 infection in combination with other antiretroviral agents.

A better understanding of the dynamics of the immune system's response to HIV may lead to more effective IFNa-based therapies.

Rare effective antibodies taken from HIV patients serve as guides to reverse engineer optimal vaccine candidates.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

Guide RNA shows promise eliminating HIV from the DNA of CD4 T cells.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

Many physicians prescribe multi-drug tuberculosis regimens in patients with HIV as a precaution.

Tuberculosis is difficult to detect in patients with HIV.

Pharmacists can also help find HIV assistance programs for patients who need help financially.

The FDA has approved Gilead Sciences' emtricitabine 200 mg/tenofovir alafenamide 25 mg (Descovy), a treatment for HIV.

New HIV cases among gay men are more likely to stem from the South than any other region in the United States.

Descovy contains 2 HIV nucleoside analog reverse transcriptase inhibitors, emtricitabine, and tenofovir alafenamide.

Descovy is not a complete regimen and must be used in combination with other antiretroviral agents for the treatment of HIV.

Risk of cardiovascular events increases in HIV patients who defer or interrupt treatment.

DNA screening technology up to 10,000 times more sensitive than current tests for cancer and HIV.

Viral load predicts immune cell response in patients with HIV.

Vitamin D supplementation modifies the body's response to HIV infection

Study shows what couples with at least 1 HIV-positive partner want to get most out of HIV counseling, which can promote health services and treatment.

Physicians were previously not authorized to use HIV-positive organ donors, even if the recipient was also HIV-positive.

When asking patients what medications they take, many often only acknowledge daily prescription medications.